The Pennant Group, Inc. (NASDAQ:PNTG) Receives $34.80 Consensus Price Target from Analysts

The Pennant Group, Inc. (NASDAQ:PNTG) has received a consensus recommendation of “Buy” from the eight analysts that are currently covering the stock, MarketBeat reports. One analyst has rated the stock with a hold recommendation, six have issued a buy recommendation and one has issued a strong buy recommendation on the company. The average 12-month price target among brokers that have covered the stock in the last year is $34.80.

PNTG has been the subject of a number of recent research reports. Jefferies Financial Group began coverage on shares of The Pennant Group in a research note on Friday, October 24th. They set a “buy” rating and a $30.00 price target for the company. Weiss Ratings reiterated a “hold (c)” rating on shares of The Pennant Group in a research report on Monday, December 8th. Wells Fargo & Company raised The Pennant Group from an “equal weight” rating to an “overweight” rating and increased their price target for the company from $29.00 to $31.00 in a research note on Tuesday, November 18th. Stephens restated an “overweight” rating and issued a $40.00 price target on shares of The Pennant Group in a research report on Thursday, October 9th. Finally, William Blair initiated coverage on The Pennant Group in a report on Monday, December 8th. They issued an “outperform” rating for the company.

Institutional Trading of The Pennant Group

A number of hedge funds have recently modified their holdings of PNTG. Cubist Systematic Strategies LLC increased its position in shares of The Pennant Group by 205.9% in the 1st quarter. Cubist Systematic Strategies LLC now owns 97,527 shares of the company’s stock valued at $2,453,000 after buying an additional 65,640 shares in the last quarter. Geode Capital Management LLC grew its stake in The Pennant Group by 4.6% in the second quarter. Geode Capital Management LLC now owns 832,481 shares of the company’s stock valued at $24,853,000 after acquiring an additional 36,357 shares during the period. Belpointe Asset Management LLC acquired a new position in The Pennant Group in the second quarter valued at about $211,000. Pinnacle Associates Ltd. bought a new stake in shares of The Pennant Group in the second quarter worth about $1,104,000. Finally, Nuveen LLC acquired a new stake in shares of The Pennant Group during the first quarter worth about $9,181,000. 85.88% of the stock is currently owned by institutional investors and hedge funds.

The Pennant Group Trading Up 0.7%

Shares of PNTG opened at $29.72 on Friday. The stock’s fifty day simple moving average is $26.06 and its 200-day simple moving average is $25.76. The firm has a market capitalization of $1.03 billion, a PE ratio of 39.63, a price-to-earnings-growth ratio of 2.39 and a beta of 1.31. The Pennant Group has a 12-month low of $21.18 and a 12-month high of $30.27. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.08.

The Pennant Group (NASDAQ:PNTG) last announced its quarterly earnings data on Wednesday, November 5th. The company reported $0.30 earnings per share for the quarter, topping the consensus estimate of $0.29 by $0.01. The Pennant Group had a return on equity of 9.37% and a net margin of 3.15%.The firm had revenue of $229.04 million during the quarter, compared to analysts’ expectations of $221.96 million. The Pennant Group has set its FY 2025 guidance at 1.140-1.180 EPS. As a group, research analysts predict that The Pennant Group will post 0.75 earnings per share for the current year.

About The Pennant Group

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.